IRIS - Res&Arch Institutional Research Information System - Research & Archive

MASSARI, SERENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 4.304
NA - Nord America 3.195
EU - Europa 2.575
SA - Sud America 300
AF - Africa 34
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 2
Totale 10.413
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.128
CN - Cina 2.438
SG - Singapore 927
IT - Italia 634
IE - Irlanda 398
VN - Vietnam 335
HK - Hong Kong 330
SE - Svezia 325
RU - Federazione Russa 280
BR - Brasile 262
UA - Ucraina 213
DE - Germania 182
FI - Finlandia 123
KR - Corea 87
GB - Regno Unito 86
BE - Belgio 73
FR - Francia 44
PL - Polonia 44
IN - India 42
AT - Austria 40
CA - Canada 31
RO - Romania 31
JP - Giappone 30
MX - Messico 28
NL - Olanda 27
TR - Turchia 26
ES - Italia 20
BD - Bangladesh 16
CZ - Repubblica Ceca 16
AR - Argentina 14
PK - Pakistan 14
CH - Svizzera 13
UZ - Uzbekistan 10
CI - Costa d'Avorio 9
ZA - Sudafrica 9
EC - Ecuador 6
ID - Indonesia 6
IQ - Iraq 6
MA - Marocco 6
AE - Emirati Arabi Uniti 5
EG - Egitto 5
GR - Grecia 5
LB - Libano 5
SA - Arabia Saudita 5
CL - Cile 4
CO - Colombia 4
IR - Iran 4
LT - Lituania 4
PE - Perù 4
EU - Europa 3
LV - Lettonia 3
AL - Albania 2
BG - Bulgaria 2
BH - Bahrain 2
CR - Costa Rica 2
DK - Danimarca 2
HU - Ungheria 2
IL - Israele 2
JM - Giamaica 2
LK - Sri Lanka 2
NO - Norvegia 2
PA - Panama 2
VE - Venezuela 2
AM - Armenia 1
AU - Australia 1
AZ - Azerbaigian 1
BO - Bolivia 1
CV - Capo Verde 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GE - Georgia 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
JO - Giordania 1
KE - Kenya 1
KH - Cambogia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
MY - Malesia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PH - Filippine 1
PY - Paraguay 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
TW - Taiwan 1
UY - Uruguay 1
Totale 10.413
Salva come PNG Salva come JPEG
Città #
Guangzhou 2.081
Singapore 633
Chandler 572
Dublin 398
Perugia 389
Hong Kong 321
Dong Ket 243
San Mateo 201
Ashburn 163
Boardman 152
Santa Clara 129
Jacksonville 108
Beijing 95
Medford 89
Princeton 88
Seoul 85
Altamura 82
Brussels 73
Ann Arbor 71
Los Angeles 66
Munich 61
Lawrence 60
Wilmington 60
Moscow 56
New York 45
Fremont 44
Andover 41
Ho Chi Minh City 40
West Jordan 38
São Paulo 37
Piscataway 35
The Dalles 34
Redmond 31
Vienna 30
Turku 29
Helsinki 27
Warsaw 27
Tokyo 26
Bucharest 25
Saint Petersburg 25
Dearborn 23
Brooklyn 21
Norwalk 20
Orem 19
Atlanta 18
Dallas 18
Hefei 18
Redwood City 17
Spoleto 16
Ankara 15
Hanoi 15
Houston 14
Montreal 14
Phoenix 14
Chicago 13
Rome 13
Denver 12
Des Moines 12
Hanover 11
Nuremberg 11
Poplar 11
Secaucus 11
Chennai 10
Council Bluffs 10
Porto Alegre 10
San Jose 10
Woodbridge 10
Abidjan 9
Columbus 9
London 9
Manchester 9
Mexico City 9
Stockholm 9
Amsterdam 8
Charlotte 8
Dhaka 8
Izmir 8
Lappeenranta 8
Olomouc 8
Seattle 8
Den Haag 7
Johannesburg 7
Querétaro 7
Radomsko 7
Rio de Janeiro 7
Bologna 6
Boston 6
Buffalo 6
Changsha 6
Curitiba 6
Falls Church 6
Frankfurt Am Main 6
Shanghai 6
Tianjin 6
Toronto 6
Anguillara Sabazia 5
Belo Horizonte 5
Biên Hòa 5
Brasília 5
Da Nang 5
Totale 7.426
Salva come PNG Salva come JPEG
Nome #
Structural investigation of Small Molecules Targeting Influenza A Virus Polymerase 2.124
1,4-Benzothiazine ATP-Sensitive Potassium Channel Openers: Modifications at the C-2 and C-6 Positions 301
1,2,4-triazolo[1,5-α]pyrimidines as a novel class of inhibitors of the HIV-1 reverse transcriptase-αssociated ribonuclease h activity 289
1,2,4-Triazolo[1,5-a]pyrimidines: Efficient One-step Synthesis and Functionalization as Influenza Polymerase PA-PB1 Interaction Disruptors 172
Engagement of Nuclear Coactivator 7 by 3-Hydroxyanthranilic Acid Enhances Activation of Aryl Hydrocarbon Receptor in Immunoregulatory Dendritic Cells 153
Functionalized 2,1-benzothiazine 2,2-dioxides as new inhibitors of Dengue NS5 RNA-dependent RNA polymerase 137
SINTESI DI NUOVI INIBITORI DELLA POMPA DI EFFLUSSO NorA DELLO S. aureus: DALLE 3-FENIL-1,4-BENZOTIAZINE ALLE 2-FENILCHINOLINE 123
Antitubercular polyhalogenated phenothiazines and phenoselenazine with reduced binding to CNS receptors 122
[1,2,4]Triazolo[3,4-b]benzothiazole Scaffold as Versatile Nicotinamide Mimic Allowing Nanomolar Inhibition of Different PARP Enzymes 121
2-Phenylquinolones as Inhibitors of the HIV-1 Tat/TAR Interaction. 117
A Broad Anti-influenza Hybrid Small Molecule that Potently Disrupts the Polymerase Acidic Protein-Basic Protein 1 (PA-PB1) Subunits Interaction 113
A 1,8-Naphthyridone Derivative Targets the HIV-1 Tat-Mediated Transcription and Potently Inhibits the HIV-1 Replication. 112
2-Phenylquinazolinones as dual-activity tankyrase-kinase inhibitors 111
Structure-activity relationship study on anti-HIV 6-desfluoroquinolones. 110
2-Phenylquinoline S. aureus NorA Efflux Pump Inhibitors: Evaluation of the Importance of Methoxy Group Introduction 110
New anti-ovarian cancer quinolone derivatives acting by modulating microRNA processing machinery 109
Discovery of potent p38α MAPK inhibitors through a funnel like workflow combining in silico screening and in vitro validation 106
Pyridobenzothiazolones Exert Potent Anti-Dengue Activity by Hampering Multiple Functions of NS5 Polymerase 105
6-Desfluoroquinolones as promising HIV transcription inhibitors 104
C-2 phenyl replacements to obtain potent quinoline-based Staphylococcus aureus NorA inhibitors 104
From cycloheptathiophene-3-carboxamide to oxazinone-based derivatives as allosteric HIV-1 ribonuclease H inhibitors 103
4-(Phenoxy) and 4-(benzyloxy)benzamides as potent and selective inhibitors of mono-ADP-ribosyltransferase PARP10/ARTD10 103
6-Hydrogen-8-Methylquinolones Active Against Replicating and Non-replicating Mycobacterium tuberculosis 102
Acting on Tat-Mediated Transcription to Achieve a Long Term Control of HIV-1 Latency 102
A New Derivative with Ultra-Potent Anti-HIV Activity 99
Targeting CDKs to inhibit the HIV-1 TAT-mediated transcription 98
Disegno e Sintesi di Nuovi Inibitori Allosterici della NS5B Polimerasi dell'HCV 97
Inhibition of Subgenomic Hepatitis C Virus RNA Replication by Acridone Derivatives: Identification of an NS3 Helicase Inhibitor. 96
From Serendipity to Rational Identification of the 5,6,7,8-Tetrahydrobenzo [4,5]thieno[2,3-d]pyrimidin-4(3H)-one Core as a New Chemotype of AKT1 Inhibitors for Acute Myeloid Leukemia 96
Computer-Aided Identification of Fragments as CDK9 Inhibitors with Anti-HIV-1 Tat-Mediated Transcription Activity 95
CYCLOHEPTATHIOPHENE-3-CARBOXAMIDE DERIVATIVES AS INFLUENZA A VIRUS POLYMERASE INHIBITORS 95
Synthesis and Characterization of 1,2,4-Triazolo[1,5-a]pyrimidine-2-carboxamide-based Compounds Targeting the PA-PB1 Interface of Influenza A Virus Polymerase. 94
Broad spectrum anti-flavivirus pyridobenzothiazolones leading to less infective virions 93
A new quinolone derivative with ultra-potent anti-HIV activity. 92
6-Desfluoroquinolones as HIV-1 Tat-mediated Transcription Inhibitors 91
Synthesis and chromatographic enantioresolution of anti-HIVquinolone derivatives 91
Pharmacophore-Based Repositioning of Approved Drugs as Novel Staphylococcus aureus NorA Efflux Pump Inhibitors 91
Chinoloni anti-HIV: studi volti all’identificazione del target molecolare 90
Design and synthesis of WM5 analogues as HIV-1 TAR RNA binders. 89
Inhibition of Influenza Virus Polymerase by Interfering with Its Protein-Protein Interactions 88
Studies on 2-phenylquinoline Staphylococcus aureus NorA efflux pump inhibitors: New insights on the C-6 position 87
Small Molecules as HIV-1 Tat-TAR Complex Inhibitors 86
2-Phenylquinazolinone fragment imparts anti-CDKs and anti-HIV activities 86
Structural Modifications of the Quinolin-4-yloxy Core to Obtain New Staphylococcus aureus NorA Inhibitors 86
From 6-Aminoquinolone Antibacterials to 6-Amino-7-thiopyranopyridinylquinolone Ethyl Esters as Inhibitors of Staphylococcus aureus Multidrug Efflux Pumps. 85
Studies on Anti-HIV Quinolones: New Insights on the C-6 Position 84
The 6-aminoquinolone WC5 inhibits human cytomegalovirus replication at an early stage by interfering with the transactivating activity of viral immediate-early 2 protein 83
Searching for innovative quinolone-like scaffolds: synthesis and biological evaluation of 2,1-benzothiazine 2,2-dioxide derivatives 83
The Pyrazolobenzothiazine Core as a New Chemotype of p38 Alpha Mitogen-Activated Protein Kinase Inhibitors 83
Efficient and regioselective one-step synthesis of 7-aryl-5-methyl- and 5-aryl-7-methyl-2-amino-[1,2,4]triazolo[1,5-a] pyrimidine derivatives 83
Sustainable, three-component, one-pot procedure to obtain active anti-flavivirus agents 83
From Quinoline to Quinazoline-Based S. aureus NorA Efflux Pump Inhibitors by Coupling a Focused Scaffold Hopping Approach and a Pharmacophore Search 83
Pyridobenzothiazole derivatives as new chemotype targeting the HCV NS5B polymerase 82
Computer-Aided Design, Synthesis and Validation of 2-Phenylquinazolinone Fragments as CDK9 Inhibitors with Anti-HIV-1 Tat-Mediated Transcription Activity 82
Studies of Anti-HIV Transcription Inhibitor Quinolones: Identification of Potent N1-Vinyl Derivatives 79
6-Aminoquinolones targeting HCV NS5B polymerase. 79
Searching for Novel Inhibitors of the S. aureus NorA Efflux Pump: Synthesis and Biological Evaluation of the 3-Phenyl-1,4-benzothiazine Analogues 79
New compounds targeting the rna polymerase of influenza a and b viruses. 78
Nuovi 6-DFQ come inibitori della Transattivazione dell’HIV-1 76
The 6-Aminoquinolone WC5 inhibits different functions of the immediate-early 2 (IE2) protein of human cytomegalovirus that are essential for viral replication 76
New C-6 functionalized quinoline NorA inhibitors strongly synergize with ciprofloxacin against planktonic and biofilm growing resistant Staphylococcus aureus strains 75
Biotinylated Tryptophan Catabolites for Target Fishing. 73
Cycloheptathiophene-3-carboxamide derivatives as influenza A virus polymerase inhibitors 72
In Vitro effects of alternative smoking devices on oral cells: Electronic cigarette and heated tobacco product versus tobacco smoke 70
Switching the three-component Biginelli-like reaction conditions for the regioselective synthesis of new 2-amino[1,2,4]triazolo[1,5-a]pyrimidines 69
Exploring the cycloheptathiophene-3-carboxamide scaffold to disrupt the interactions of the influenza polymerase subunits and obtain potent anti-influenza activity 69
Small Molecules Targeting DNA Polymerase Theta (POLθ) as Promising Synthetic Lethal Agents for Precision Cancer Therapy 68
Disegno e sintesi di agenti anti-HIV a duplice attività 68
Designed Multiple Ligands (DLMs) as innovative anti-HIV agents 68
Re-evolution of the 2-phenylquinolines: Ligand-Based Design, Synthesis, and Biological Evaluation of a Potent New Class of Staphylococcus aureus NorA Efflux Pump Inhibitors to Combat Antimicrobial Resistance 68
Potent 2,3-dihydrophthalazine-1,4-dione derivatives as dual inhibitors for mono-ADP-ribosyltransferases PARP10 and PARP15 66
Phospholipidosis effect of drugs by adsorption into lipid monolayers 66
Modifications on C6 and C7 Positions of 3-Phenylquinolone Efflux Pump Inhibitors Led to Potent and Safe Antimycobacterial Treatment Adjuvants 65
Small molecole targeting HPV E6 and E7 oncoproteins expression. 63
Natural isoflavone biochanin A as a template for the design of new and potent 3-phenylquinolone efflux inhibitors against Mycobacterium avium 63
Compounds for use in the treatment of cancer and inflammatory conditions 63
Nuovi 6-DFQ come inibitori della transattivazione dell’HIV-1. Abstr O15 62
Exploiting the anti-HIV 6-desfluoroquinolones to design multiple ligands 62
Discovery of 2‐phenylquinazolines as potent Mycobacterium avium efflux pump inhibitors able to synergize with clarithromycin against clinical isolate 61
Design, Synthesis, and Evaluation of WC5 Analogues as Inhibitors of Human Cytomegalovirus Immediate-Early 2 Protein, a Promising Target for Anti-HCMV Treatment 61
Polymerase Acidic Protein-Basic Protein 1 (PA-PB1) Protein-protein Interaction as a Target for Next-generation Anti-influenza Therapeutics. 61
Potent and broad-spectrum cycloheptathiophene-3-carboxamide compounds that target the PA-PB1 interaction of influenza virus RNA polymerase and possess a high barrier to drug resistance 60
Discovery of 2-Phenylquinolines with Broad-Spectrum Anti-coronavirus Activity 58
Optimization of potent, broad-spectrum, and specific anti-influenza compounds targeting RNA polymerase PA-PB1 heterodimerization 58
SMALL MOLECULES TARGETING HPV E6 AND E7 ONCOPROTEINS EXPRESSION 56
Structural investigation of the naphthyridone scaffold: identification of a 1,6-naphthyridone derivative with potent and selective anti-HIV activity. 55
Triazolopyrimidine nuclei: privileged scaffolds for developing antiviral agents with a proper pharmacokinetic profile. 55
Targeting the HIV Tat-mediated transcriptional machinery: P-TEFb complex inhibitors 54
Reducing Mutant Huntingtin Protein Expression in Living Cells by a Newly Identified RNA CAG Binder. 54
Studies on Cycloheptathiophene-3-carboxamide Derivatives as Allosteric HIV-1 Ribonuclease H Inhibitors 53
Blocking HIV-1 Replication by Targeting the TAT-Hijacked Transcriptional Machinery 52
Studies on anti-HIV Quinolones 51
TARGETING CDKs TO INHIBIT THE HIV-1 TAT-MEDIATED TRANSCRIPTION 51
Structural Investigation of Cycloheptathiophene-3-carboxamide Derivatives Targeting Influenza Virus Polymerase Assembly 50
Ethyl 1,8-Naphthyridone-3-carboxylates Downregulate Human Papillomavirus-16 (HPV-16) E6 and E7 Oncogenes Expression 50
Q-raKtion: A Semiautomated KNIME Workflow for Bioactivity Data Points Curation 49
From Small to Powerful: The Fragments Universe and its "Chem-Appeal" 47
NM13, UN NUOVO POTENTE E SELETTIVO AGENTE ANTI-HIV 45
Protein-protein interactions by influenza polymerase subunits as drug targets 41
Synergistic activity of an RNA polymerase PA-PB1 interaction inhibitor with oseltamivir against human and avian influenza viruses in cell culture and in ovo 38
Totale 10.661
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.739
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.739
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021571 0 0 0 0 0 81 87 5 71 31 37 259
2021/2022940 31 144 18 66 73 7 24 242 69 35 111 120
2022/20231.588 96 281 19 161 155 151 3 102 514 15 57 34
2023/20242.830 39 116 37 24 14 22 2.246 16 57 57 78 124
2024/20251.852 19 150 65 139 186 108 246 121 305 113 254 146
2025/20261.861 239 245 173 476 506 222 0 0 0 0 0 0
Totale 10.762